Alto Neuroscience Inc. (ANRO)
undefined
undefined%
At close: undefined
3.93
4.66%
After-hours Dec 16, 2024, 04:37 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21
Net Income -36.30M -27.71M -9.19M
Depreciation & Amortization 373.00K 342.00K 145.00K
Stock-Based Compensation 2.89M 1.76M 227.00K
Other Working Capital -391.00K 2.42M 255.00K
Other Non-Cash Items 291.00K 915.00K 1.47M
Deferred Income Tax - - -
Change in Working Capital -698.00K 4.58M -572.00K
Operating Cash Flow -33.45M -20.39M -9.26M
Capital Expenditures -470.00K -732.00K -680.00K
Acquisitions - - -
Purchase of Investments - - -
Sales Maturities Of Investments - - -
Other Investing Acitivies - - -
Investing Cash Flow -470.00K -732.00K -680.00K
Debt Repayment - 9.82M -
Common Stock Repurchased - - -
Dividend Paid - - -
Other Financial Acitivies 67.95M 33.92M 31.68M
Financial Cash Flow 68.13M 43.79M 31.69M
Net Cash Flow 34.20M 22.64M 21.70M
Free Cash Flow -33.92M -21.13M -9.94M